Global Investigations & Compliance
Brian has conducted hundreds of internal investigations into alleged misconduct around the world and has represented corporations, boards, and individuals before the DOJ, SEC, OFAC, BIS, the UK Serious Fraud Office, the Hong Kong SFC, and other regulators. As General Counsel of GSK China, he ran the company’s response to a landmark criminal bribery case from the ground in Shanghai, reporting directly to the global CEO in London. He dealt directly with senior Chinese government officials in Mandarin and obtained declinations from the U.S. DOJ and the U.K. SFO in parallel proceedings.
Internal Investigations
Dozens of internal and independent investigations for multinational corporations and board committees, arising from whistleblower reports, audit findings, compliance training, and other sources. Privileged and discreet, designed to withstand regulatory, auditor, and market scrutiny, with efficient scoping and flat-fee billing.
Government Investigations
Representation before the DOJ, SEC, OFAC, BIS, FinCEN, and other U.S. and foreign authorities, from first inquiry through resolution.
Crisis Prevention & Management
Strategic counsel to leadership on sensitive, fast-moving matters carrying legal, commercial, and reputational consequences.
Compliance Programs
Designed corporate compliance programs for multinational clients, covering anti-corruption, antitrust, anti-money-laundering, and sanctions, together with policies governing acceptable use of social media and instant messaging, benchmarked against DOJ guidance and market practice.
Compliance Due Diligence
Unlike deal counsel, Brian has no stake in whether a transaction closes, which allows him to take an objective and independent view of a target’s or counterparty’s suitability, drawn from having conducted diligence on transactions worth over $20B in total.
Cross-Border Counseling & Risk Advisory
Guidance on enterprise risks arising from global operations, including supply-chain integrity, export controls, economic sanctions, corruption, and third-party due diligence, informed by more than a dozen risk assessments performed for Fortune 500 clients operating in high-risk jurisdictions.
Case Studies
Additional Matters
Advised a U.S.-listed medtech company on investigations and compliance matters in South Korea and Indonesia.
Designed and implemented a global compliance program for a leading international luxury fashion group and conducted multiple compliance reviews.
Representing a U.S.-listed biotechnology company in a criminal investigation by the DOJ into alleged manipulation of clinical trial data.
Representing a U.S.-listed technology company in SEC and DOJ investigations into alleged securities fraud and data protection breaches.
Representing a U.S. fintech company in a criminal investigation by the DOJ relating to alleged anti-money-laundering and Bank Secrecy Act violations.
Conducted compliance due diligence and risk assessments for venture capital and private equity firms on investments totaling over $10 billion.
Representing a U.S.-based start-up aviation financing company in an investigation by the Bureau of Industry and Security into alleged diversion in violation of U.S. export controls prohibiting shipments to Russia.
Advising the board of a U.S.-listed electronic design automation company on an internal investigation in China running alongside a parallel investigation of public officials by the Chinese Commission on Discipline and Inspection.
Guiding a U.S.-listed semiconductor company on multiple investigations in mainland China, Taiwan, and India.
Advising multiple global healthcare companies on compliance and internal investigations across China, South Korea, Japan, India, and other countries in Asia.
Performed independent due diligence on three potential licensing targets in China for a global life sciences company, leading the client to rule out two candidates that later drew adverse media attention over their ethical practices.
Advised a global medical device manufacturer on a politically sensitive reduction of its distributor network in China, managing government relations without creating corruption exposure in the process.
20+ Years Advising Fortune 500 Companies and Boards
Hundreds of Internal Investigations Worldwide
Declinations Obtained from the DOJ, SEC, and SFO
Chambers-Ranked
Admitted in New York and Hong Kong